6-32064851-C-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001365276.2(TNXB):​c.6811G>C​(p.Val2271Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00523 in 1,611,140 control chromosomes in the GnomAD database, including 106 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0049 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0053 ( 102 hom. )

Consequence

TNXB
NM_001365276.2 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -2.25
Variant links:
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004063517).
BP6
Variant 6-32064851-C-G is Benign according to our data. Variant chr6-32064851-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 261151.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-32064851-C-G is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00486 (740/152332) while in subpopulation EAS AF= 0.0135 (70/5180). AF 95% confidence interval is 0.011. There are 4 homozygotes in gnomad4. There are 399 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNXBNM_001365276.2 linkc.6811G>C p.Val2271Leu missense_variant Exon 19 of 44 ENST00000644971.2 NP_001352205.1
TNXBNM_001428335.1 linkc.7552G>C p.Val2518Leu missense_variant Exon 20 of 45 NP_001415264.1
TNXBNM_019105.8 linkc.6811G>C p.Val2271Leu missense_variant Exon 19 of 44 NP_061978.6 P22105-1O95680Q9Y464O95681

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNXBENST00000644971.2 linkc.6811G>C p.Val2271Leu missense_variant Exon 19 of 44 NM_001365276.2 ENSP00000496448.1 P22105-3
TNXBENST00000647633.1 linkc.7552G>C p.Val2518Leu missense_variant Exon 20 of 45 ENSP00000497649.1 A0A3B3ISX9
TNXBENST00000375244.7 linkc.6811G>C p.Val2271Leu missense_variant Exon 19 of 44 5 ENSP00000364393.3 P22105-3

Frequencies

GnomAD3 genomes
AF:
0.00487
AC:
741
AN:
152214
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00152
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00661
Gnomad ASJ
AF:
0.0251
Gnomad EAS
AF:
0.0135
Gnomad SAS
AF:
0.0135
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.00485
Gnomad OTH
AF:
0.00669
GnomAD3 exomes
AF:
0.00653
AC:
1591
AN:
243792
Hom.:
18
AF XY:
0.00731
AC XY:
976
AN XY:
133472
show subpopulations
Gnomad AFR exome
AF:
0.000628
Gnomad AMR exome
AF:
0.00448
Gnomad ASJ exome
AF:
0.0283
Gnomad EAS exome
AF:
0.0115
Gnomad SAS exome
AF:
0.0122
Gnomad FIN exome
AF:
0.000511
Gnomad NFE exome
AF:
0.00453
Gnomad OTH exome
AF:
0.0110
GnomAD4 exome
AF:
0.00526
AC:
7680
AN:
1458808
Hom.:
102
Cov.:
30
AF XY:
0.00568
AC XY:
4119
AN XY:
725718
show subpopulations
Gnomad4 AFR exome
AF:
0.00206
Gnomad4 AMR exome
AF:
0.00481
Gnomad4 ASJ exome
AF:
0.0296
Gnomad4 EAS exome
AF:
0.0400
Gnomad4 SAS exome
AF:
0.0119
Gnomad4 FIN exome
AF:
0.000710
Gnomad4 NFE exome
AF:
0.00311
Gnomad4 OTH exome
AF:
0.00652
GnomAD4 genome
AF:
0.00486
AC:
740
AN:
152332
Hom.:
4
Cov.:
32
AF XY:
0.00536
AC XY:
399
AN XY:
74492
show subpopulations
Gnomad4 AFR
AF:
0.00149
Gnomad4 AMR
AF:
0.00660
Gnomad4 ASJ
AF:
0.0251
Gnomad4 EAS
AF:
0.0135
Gnomad4 SAS
AF:
0.0135
Gnomad4 FIN
AF:
0.000471
Gnomad4 NFE
AF:
0.00485
Gnomad4 OTH
AF:
0.00662
Alfa
AF:
0.00708
Hom.:
11
Bravo
AF:
0.00521
TwinsUK
AF:
0.00270
AC:
10
ALSPAC
AF:
0.00208
AC:
8
ESP6500AA
AF:
0.000797
AC:
2
ESP6500EA
AF:
0.00588
AC:
30
ExAC
AF:
0.00622
AC:
736
Asia WGS
AF:
0.0110
AC:
39
AN:
3478
EpiCase
AF:
0.00649
EpiControl
AF:
0.00747

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

May 24, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Sep 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

TNXB: BP4, BS1, BS2 -

Jul 19, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Ehlers-Danlos syndrome Benign:1
Feb 08, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Cardiovascular phenotype Benign:1
Feb 12, 2019
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.80
CADD
Benign
0.0040
DANN
Benign
0.81
DEOGEN2
Benign
0.034
T;.;T
Eigen
Benign
-1.7
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.0035
N
LIST_S2
Benign
0.077
.;T;T
MetaRNN
Benign
0.0041
T;T;T
MetaSVM
Benign
-0.91
T
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.89
.;.;N
REVEL
Benign
0.025
Sift
Benign
0.30
.;.;T
Sift4G
Benign
0.28
.;.;T
Vest4
0.057
MVP
0.12
ClinPred
0.0038
T
GERP RS
-8.3
Varity_R
0.070

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs140770834; hg19: chr6-32032628; API